{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T10:14:40Z","timestamp":1755598480209},"reference-count":31,"publisher":"Ubiquity Press, Ltd.","issue":"3","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["gh"],"DOI":"10.1016\/j.gheart.2019.07.001","type":"journal-article","created":{"date-parts":[[2019,8,23]],"date-time":"2019-08-23T20:09:53Z","timestamp":1566590993000},"page":"295","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Contrast-Induced Nephropathy in Patients With ST-Segment Elevation\n                        Myocardial Infarction: Is it Affected by Treatment Strategy?"],"prefix":"10.5334","volume":"14","author":[{"given":"Mohamed","family":"Khalfallah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Abdalaal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mona","family":"Adel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3285","published-online":{"date-parts":[[2019,9,1]]},"reference":[{"issue":"100","key":"10.1016\/j.gheart.2019.07.001_bib1","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1038\/sj.ki.5000368","article-title":"Contrast-induced nephropathy: definition, epidemiology, and patients at risk","author":"Mehran","year":"2006","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.gheart.2019.07.001_bib2","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jacc.2013.04.105","volume":"63","author":"Leoncini","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.gheart.2019.07.001_bib3","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1053\/ajkd.2002.32766","article-title":"Hospital-acquired renal insufficiency","volume":"39","author":"Nash","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.gheart.2019.07.001_bib4","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1161\/CIRCINTERVENTIONS.112.974493","article-title":"Contrast-induced acute kidney injury and risk of adverse clinical outcomes after coronary angiography: a systematic review and meta-analysis","volume":"6","author":"James","year":"2013","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.gheart.2019.07.001_bib5","first-page":"439","article-title":"Reperfusion options for ST elevation myocardial infarction patients with expected delays to percutaneous coronary intervention","volume":"5","author":"Larson","year":"2016","journal-title":"Interv Cardiol Clin"},{"key":"10.1016\/j.gheart.2019.07.001_bib6","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1016\/j.amjcard.2016.03.036","article-title":"Pharmacoinvasive and primary percutaneous coronary intervention strategies in ST-elevation myocardial infarction (from the Mayo Clinic STEMI Network)","volume":"117","author":"Siontis","year":"2016","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.gheart.2019.07.001_bib7","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1161\/CIRCULATIONAHA.107.762765","volume":"118","author":"Danchin","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.gheart.2019.07.001_bib8","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1016\/j.jacc.2004.07.043","article-title":"Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction","volume":"44","author":"Marenzi","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.gheart.2019.07.001_bib9","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/MAJ.0b013e318068ddf9","article-title":"Risk markers for contrast-induced nephropathy","volume":"334","author":"Toprak","year":"2007","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.gheart.2019.07.001_bib10","first-page":"S1","article-title":"K\/DOQI clinical practice guide-lines for chronic kidney disease: evaluation, classification, and stratification","volume":"39","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.gheart.2019.07.001_bib11","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1001\/archinte.162.3.329","article-title":"Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty","volume":"162","author":"Mueller","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.gheart.2019.07.001_bib12","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1590\/S0066-782X2006001600023","article-title":"Contrast media-induced nephropathy following diagnostic and therapeutic cardiac catheterization","volume":"87","author":"Ultramari","year":"2006","journal-title":"Arq Bras Cardiol"},{"key":"10.1016\/j.gheart.2019.07.001_bib13","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1016\/j.amjcard.2014.02.004","article-title":"Validation of a new risk score to predict contrast-induced nephropathy after percutaneous coronary intervention","volume":"113","author":"Tziakas","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.gheart.2019.07.001_bib14","first-page":"439","article-title":"Contrast-induced nephropathy after primary angioplasty for acute myocardial infarction","volume":"37","author":"Santos","year":"2015","journal-title":"J\u00a0Bras Nefrol"},{"key":"10.1016\/j.gheart.2019.07.001_bib15","first-page":"1393","article-title":"A\u00a0simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation","volume":"44","author":"Mehran","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.gheart.2019.07.001_bib16","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1157\/13111234","article-title":"Contrast-induced nephropathy and acute renal failure following emergent cardiac catheterization: incidence, risk factors and prognosis","volume":"60","author":"Bouzas-Mosquera","year":"2007","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.gheart.2019.07.001_bib17","first-page":"e06380","article-title":"Association between acidosis soon after reperfusion and contrast-induced nephropathy in patients with a first-time ST-segment elevation myocardial infarction","volume":"6","author":"Gohbara","year":"2017","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.gheart.2019.07.001_bib18","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/S0735-1097(00)00866-4","article-title":"Short- and long-term mortality for patients undergoing primary angioplasty for acute myocardial infarction","volume":"36","author":"Hannan","year":"2000","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.gheart.2019.07.001_bib19","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1002\/ccd.25023","article-title":"Age, glomerular filtration rate, ejection fraction, and the AGEF score predict contrast-induced nephropathy in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention","volume":"82","author":"Ando","year":"2013","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.gheart.2019.07.001_bib20","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1253\/circj.CJ-13-0574","article-title":"Clinical predictors of contrast-induced acute kidney injury in patients undergoing emergency versus elective percutaneous coronary intervention","volume":"78","author":"Abe","year":"2014","journal-title":"Circ J"},{"key":"10.1016\/j.gheart.2019.07.001_bib21","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1161\/CIRCINTERVENTIONS.114.001545","article-title":"Renal function-adjusted contrast volume redefines the baseline estimation of contrast-induced acute kidney injury risk in patients undergoing primary percutaneous coronary intervention","volume":"7","author":"Ando","year":"2014","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.gheart.2019.07.001_bib22","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1253\/circj.CJ-14-0117","article-title":"Admission hyperglycemia is an independent predictor of acute kidney injury in patients with acute myocardial infarction","volume":"78","author":"Moriyama","year":"2014","journal-title":"Circ J"},{"key":"10.1016\/j.gheart.2019.07.001_bib23","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/j.amjcard.2016.07.069","article-title":"Usefulness of C-reactive protein as a predictor of contrast-induced nephropathy after percutaneous coronary interventions in patients with acute myocardial infarction and presentation of a new risk score (Athens CIN Score)","volume":"118","author":"Lazaros","year":"2016","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.gheart.2019.07.001_bib24","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s12928-015-0337-1","article-title":"Impact of minimum contrast media volumes during elective percutaneous coronary intervention for prevention of contrast-induced nephropathy in patients with stable coronary artery disease","volume":"31","author":"Ebisawa","year":"2016","journal-title":"Cardiovasc Interv Ther"},{"key":"10.1016\/j.gheart.2019.07.001_bib25","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1148\/radiol.13122876","article-title":"Quantitating contrast medium-induced nephropathy: controlling the controls","volume":"267","author":"Newhouse","year":"2013","journal-title":"Radiology"},{"key":"10.1016\/j.gheart.2019.07.001_bib26","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1523-1755.2005.00377.x","article-title":"Pathophysiology of contrast medium-induced nephropathy","volume":"68","author":"Persson","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.gheart.2019.07.001_bib27","doi-asserted-by":"crossref","first-page":"e002212","DOI":"10.1161\/CIRCINTERVENTIONS.114.002212","article-title":"Association between acute kidney injury and in-hospital mortality in patients undergoing percutaneous coronary interventions","volume":"8","author":"Kooiman","year":"2015","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.gheart.2019.07.001_bib28","doi-asserted-by":"crossref","first-page":"170","DOI":"10.7326\/0003-4819-150-3-200902030-00006","article-title":"Contrast volume during primary percutaneous coronary intervention and subsequent contrast induced nephropathy and mortality","volume":"150","author":"Marenzi","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.gheart.2019.07.001_bib29","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1093\/eurheartj\/ehu063","article-title":"Contrast-induced acute kidney injury after primary percutaneous coronary intervention: results from the HORIZONS-AMI substudy","volume":"35","author":"Narula","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.gheart.2019.07.001_bib30","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.gheart.2018.06.003","article-title":"Very early versus early percutaneous coronary intervention after successful fibrinolytic therapy in pharmacoinvasive strategy","volume":"13","author":"Khalfallah","year":"2018","journal-title":"Glob Heart"},{"key":"10.1016\/j.gheart.2019.07.001_bib31","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1161\/01.CIR.0000016043.87291.33","article-title":"Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention","volume":"105","author":"Rihal","year":"2002","journal-title":"Circulation"}],"container-title":["Global Heart"],"original-title":[],"link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211816019301127?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211816019301127?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/doi.org\/10.1016\/j.gheart.2019.07.001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,11]],"date-time":"2022-07-11T12:50:14Z","timestamp":1657543814000},"score":1,"resource":{"primary":{"URL":"https:\/\/globalheartjournal.com\/article\/10.1016\/j.gheart.2019.07.001\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,1]]},"references-count":31,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2019,9,1]]}},"URL":"https:\/\/doi.org\/10.1016\/j.gheart.2019.07.001","relation":{},"ISSN":["2211-8179","2211-8160"],"issn-type":[{"value":"2211-8179","type":"electronic"},{"value":"2211-8160","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Contrast-Induced Nephropathy in Patients With ST-Segment Elevation Myocardial Infarction","name":"articletitle","label":"Article Title"},{"value":"Global Heart","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gheart.2019.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 World Heart Federation (Geneva). Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}